Consistent with predictions based on our experimental data, correlative analyses showed that NSCLC progresses faster in TCGA patients with an elevated expression of CXCR4, VAV1, and L1CAM (Fig. 6 G). Here, CXCR4 is linked to non-small cell lung carcinoma.